Corcept Therapeutics (CORT) EBITDA (2010 - 2026)
Corcept Therapeutics (CORT) reported EBITDA of $42.16 million for Q2 2026, up 55.3% from $27.14 million a year earlier.
Powered by 
Analysis
Corcept Therapeutics (CORT) EBITDA (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Corcept Therapeutics' EBITDA came in at $8.08 million, down 92.2% year-over-year; for FY2025, it was $45.95 million, down 66.6% from FY2024.
- EBITDA has a five-year compound annual growth rate of -18.6% (FY2020 to FY2025).
- By year, EBITDA came in at $137.75 million in FY2024 (+26.6%), $108.79 million in FY2023 (-4.9%), $114.37 million in FY2022 (-9.2%) and $125.96 million in FY2021 (-2.2%).
- The Q2 2026 figure ranks as the highest quarterly EBITDA since Q3 2024.
- Year over year, EBITDA gained in two of the last seven quarters, with an average decline of 26.5%.
- The high point for year-over-year EBITDA in five years was Q1 2024 (growth of 95.9%); the low point was Q1 2025 (a decline of 86.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$49 million (Q1 2026), $4.78 million (Q4 2025) and $10.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 42.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.16 Mn |
| Mar 31, 2026 | -49.00 Mn |
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 10.15 Mn |
| Jun 30, 2025 | 27.14 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Dec 31, 2024 | 25.54 Mn |
| Sep 30, 2024 | 46.92 Mn |
| Jun 30, 2024 | 35.67 Mn |
| Mar 31, 2024 | 29.67 Mn |
| Dec 31, 2023 | 31.88 Mn |
| Sep 30, 2023 | 31.41 Mn |
| Jun 30, 2023 | 30.01 Mn |
| Mar 31, 2023 | 15.14 Mn |
| Dec 31, 2022 | 23.16 Mn |
| Sep 30, 2022 | 32.13 Mn |
| Jun 30, 2022 | 31.55 Mn |
| Mar 31, 2022 | 27.06 Mn |
| Dec 31, 2021 | 36.95 Mn |
| Sep 30, 2021 | 34.54 Mn |
API Access
Corcept Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();